Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?

被引:3
作者
Sedano Munoz, Rocio [1 ]
Quera Pino, Rodrigo [2 ]
Ibanez Lazo, Patricio [2 ]
Figueroa Corona, Carolina [2 ]
Flores Perez, Lilian [2 ]
机构
[1] Univ Chile, Hosp Clin, Serv Gastroenterol, Santiago, Chile
[2] Clin Las Condes, Serv Gastroenterol, Programa Enfermedad Inflamatoria Intestinal, Santiago, Chile
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2019年 / 42卷 / 05期
关键词
Inflammatory bowel disease; Mesalazine; Thiopurines; Azathioprine; Mercaptopurine; Methotrexate; Biological therapy withdrawal; RANDOMIZED CONTROLLED-TRIAL; ACTIVE RECTAL INFLAMMATION; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; CROHNS-DISEASE; LONG-TERM; MAINTENANCE TREATMENT; DOUBLE-BLIND; RISK-FACTORS; HISTOLOGICAL REMISSION;
D O I
10.1016/j.gastrohep.2019.01.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The current goals of treatment in inflammatory bowel disease, both Crohn's disease and ulcerative colitis, are to achieve clinical, endoscopic and ideally histological remission and improve the quality of life of these patients. Current therapies are effective in achieving remission in most cases, but there is a lack of clear guidelines on their optimal duration. This review aims to evaluate the current evidence on the withdrawal of therapy with 5-aminosalicylates, thiopurines and methotrexate. We also aim to identify which specific group of patients, while in remission and in the absence of risk factors, may be able to discontinue therapy without a significant risk of relapse. (C) 2019 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 96 条
[21]   Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study [J].
Cheddani, Halima ;
Dauchet, Luc ;
Fumery, Mathurin ;
Charpentier, Cloe ;
Bouvier, Anne Marie ;
Dupas, Jean-Louis ;
Pariente, Benjamin ;
Peyrin-Biroulet, Laurent ;
Savoye, Guillaume ;
Gower-Rousseau, Corinne .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (10) :1428-1436
[22]   Upper Gastrointestinal Tract Phenotype of Crohn's Disease Is Associated with Early Surgery and Further Hospitalization [J].
Chow, Dorothy K. L. ;
Sung, Joseph J. Y. ;
Wu, Justin C. Y. ;
Tsoi, Kelvin K. F. ;
Leong, Rupert W. L. ;
Chan, Francis K. L. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (04) :551-557
[23]   Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes [J].
Christensen, Britt ;
Hanauer, Stephen B. ;
Erlich, Jonathan ;
Kassim, Olufemi ;
Gibson, Peter R. ;
Turner, Jerrold R. ;
Hart, John ;
Rubin, David T. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (10) :1557-+
[24]   Effects of cigarette smoking on the long-term course of Crohn's disease [J].
Cosnes, J ;
Carbonnel, F ;
Beaugerie, L ;
LeQuintrec, Y ;
Gendre, JP .
GASTROENTEROLOGY, 1996, 110 (02) :424-431
[25]   Gender Differences in the Response of Colitis to Smoking [J].
Cosnes, Jacques ;
Nion-larmurier, Isabelle ;
Afchain, Pauline ;
Beaugerie, Laurent ;
Gendre, Jean-pierre .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (01) :41-48
[26]   Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease [J].
D'Haens, Geert ;
Ferrante, Marc ;
Vermeire, Severine ;
Baert, Filip ;
Noman, Maja ;
Moortgat, Liesbeth ;
Geens, Patricia ;
Iwens, Doreen ;
Aerden, Isolde ;
Van Assche, Gert ;
Van Olmen, Gust ;
Rutgeerts, Paul .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2218-2224
[27]  
Dias CC, 2017, J CROHNS COLITIS, V11, P445, DOI 10.1093/ecco-jcc/jjw171
[28]   Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies [J].
Dias, Claudia Camila ;
Rodrigues, Pedro Pereira ;
da Costa-Pereira, Altamiro ;
Magro, Fernando .
JOURNAL OF CROHNS & COLITIS, 2015, 9 (02) :156-163
[29]   CONTROLLED THERAPEUTIC TRIAL OF LONG-TERM MAINTENANCE TREATMENT OF ULCERATIVE-COLITIS WITH SULFASALAZINE (SALAZOPYRIN) [J].
DISSANAYAKE, AS ;
TRUELOVE, SC .
GUT, 1973, 14 (12) :923-926
[30]  
Figueroa C, 2018, REV MED CLIN CONDES, V29, P570, DOI 10.1016/j.rmclc.2018.04.013